Acclarent TruDi Navigation System Was Alleged to Have Misguided Sinus Surgery, Reportedly Contributing to Patient's Stroke

During a reported sinus procedure in Texas, Acclarent's AI-enabled TruDi Navigation System was alleged to have misinformed surgeon Marc Dean about the position of his instruments inside patient Erin Ralph's head, purportedly contributing to carotid-artery injury and a stroke. Reuters reported that Ralph later sued, alleging the system's AI contributed to her injuries. Acclarent and Integra denied a causal connection.

Risk classification

• Primary risk domain: 7 AI system safety, failures, & limitations
• Primary risk subdomain: 7.3 Lack of capability or robustness

The TruDi system failed to perform reliably, misinforming surgeons about instrument locations and leading to severe surgical errors and patient injuries.

Additional risk subdomains

• 6.5 Governance failure: The report highlights that the FDA is struggling to keep pace with AI medical devices due to staff cuts and an outdated regulatory framework.

Causal factors

• Entity: AI
• Intent: Unintentional
• Timing: Post-deployment

The physical injuries and malfunctions were caused by the TruDi AI system providing inaccurate navigation data after it was deployed in active surgeries.

EU AI Act risk tier

• Risk tier: 2 High Risk

High Risk: The system is an AI-enhanced medical device used in healthcare for surgical navigation, which has significant implications for patient safety.

AI system and alleged parties

• AI system: TruDi Navigation System (Acclarent)
• AI purpose: Navigation Assistant; Medical Diagnosis Support
• Behaviour type: Assistant
• Alleged developer: Acclarent
• Alleged deployer: Marc Dean
• Alleged harmed parties: Erin Ralph

Harm severity

Severity ratings are based on this scale.

Highest direct severity in any category: Substantial. Severity is scored from Negligible to Catastrophic in each harm category, for harm the reports describe as caused directly or indirectly by the AI system.

• Physical: direct Substantial, indirect Negligible
• Infrastructure: direct Negligible, indirect Negligible
• Property: direct Negligible, indirect Negligible
• Financial: direct Negligible, indirect Minor
• Environmental: direct Negligible, indirect Negligible
• Malicious content: direct Negligible, indirect Negligible
• Differential treatment: direct Negligible, indirect Negligible
• Civil rights: direct Negligible, indirect Negligible
• Democracy: direct Negligible, indirect Negligible
• Privacy: direct Negligible, indirect Negligible
• Psychological: direct Negligible, indirect Negligible
• Epistemic: direct Negligible, indirect Negligible
• Child sexual exploitation and abuse: direct Negligible, indirect Negligible

Physical

Reported: The report explicitly describes physical injuries to at least 10 patients during surgeries using the AI system.

Directly caused: At least 10 people were injured, including cerebrospinal fluid leaks, a punctured skull base, and major artery damage leading to strokes in two patients.

Inferred additional harm: It is likely that other unconfirmed adverse events among the 100 reported to the FDA also resulted in physical harm or complications, though details are not provided.

Financial

Reported: The report mentions lawsuits and a GoFundMe campaign but does not explicitly quantify the total financial losses.

Indirectly caused: Patients suffered financial losses from medical bills, rehabilitation, and potential loss of income, as indicated by a GoFundMe campaign for [PERSON_005].

Inferred additional harm: Significant financial losses from medical expenses, ongoing therapy, and legal fees are highly likely for the injured patients, potentially reaching hundreds of thousands of dollars.

People affected

• Occurrences reported: 100
• People reportedly harmed: 10
• People reportedly exposed: 100

Potential causes

Management

• Prioritizing Marketing Over Safety: AI was pushed primarily as a marketing tool to claim novel technology.
• Ignoring Expert Warnings: Management ignored warnings from consulting surgeon about system issues.

Technology

• 80% Accuracy Target: Acclarent set a goal of only 80% accuracy before integrating the AI.
• Inaccurate Path Calculation: Algorithm misinformed surgeons about instrument locations during operations.

Human Factors

• Surgeon Reliance on AI: Surgeons relied on faulty real-time feedback to position instruments.

Process and Methods

• Rushed to Market: Acclarent lowered safety standards to rush the AI technology to market.
• No Patient Clinical Trials: FDA rules allowed authorization without testing the AI device on patients.

Regulatory Environment

• FDA Staffing Cuts: DOGE budget cuts laid off key AI scientists, doubling reviewer workloads.
• Outdated Regulatory Approach: Traditional FDA framework is not up to task of ensuring AI device safety.

Information quality

• Classification confidence: High
• Reason for confidence: The report provides detailed accounts of specific patient injuries, FDA adverse event statistics, and regulatory context. While the manufacturer disputes causality, the occurrence of the malfunctions and injuries is well-documented through FDA reports and lawsuits.
• Ambiguities identified: The exact causal role of the AI in the surgical errors is legally disputed and unconfirmed by the FDA.
• Alternative interpretations: The injuries could be attributed entirely to human surgeon error rather than AI malfunction, as argued by the manufacturer.

The TruDi surgical navigation system malfunction represents a significant clinical safety and regulatory failure, resulting in patient injuries. However, it lacks national security implications, as it is a localized medical product liability issue manageable under standard FDA and healthcare procedures.

• Overall national security impact: Negligible
• Scope: Single nation
• Primary target: United States
• Alleged perpetrator: Unknown

Threat characteristics

• Imminence: Long-term. This represents an ongoing regulatory and software quality assurance challenge rather than an active national security crisis.
• Autonomy: Human-supervised. The system acts as a navigation assistant, providing real-time feedback to a human surgeon who retains final control over the instruments.
• Novelty: Evolved capability. Represents an evolution of software failures in medical devices, specifically involving machine-learning algorithms in surgical navigation.

Impact by dimension

• Physical security: Negligible. The incident involves a medical device malfunction causing localized patient injuries. While healthcare is critical infrastructure, this is a clinical safety and product liability issue with negligible national security impact.
• Information security: Negligible. No information warfare, espionage, or intelligence compromise is associated with this incident.
• Sovereignty: Negligible. The incident highlights regulatory challenges for the FDA, but does not threaten state authority, territorial control, or core government operations.
• Economic security: Negligible. There is no indication of strategic technology theft, financial system attacks, or disruption to critical supply chains.
• Societal stability: Negligible. The incident does not involve mass surveillance, civil unrest, or systematic human rights violations.